Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine vs Rituximab in Steroid-Refractory Primary Warm AIHA
NCT05057468Phase 3Recruiting
- Sponsor
- Assiut University
- Start
- Oct 2021
- Primary completion
- Nov 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in warm autoimmune hemolytic anemia (wAIHA), sponsored by Assiut University. Started Oct 2021; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
warm autoimmune hemolytic anemia (wAIHA)
Beyond the preview
Go deeper on NCT05057468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05057468.